Maximizing the Impact of Medical Affairs in Hematology Product Launches: Timeline, Resources, and Preparedness

With competition keen among pharma companies to successfully launch new hematology products in a timely manner, organizations are turning to their medical experts to support launches. As a key conduit between pharma companies and key opinion leaders, Medical Affairs has become one of the key players in hematology product launches.

In order to maximize hematology launch impact, Medical Affairs groups need to develop and maintain a strategic timeline for launch activities; deploy resources at appropriate points in this timeline; and ensure that launch preparedness metrics are used to ensure activities adhere to the timeline - all of which can help determine the ultimate success of a new hematology product.

Best Practices, LLC conducted this benchmarking research to explore how Medical Affairs can maximize its hematology launch impact. This study provides insights and benchmarks around staffing, budgeting, timeline, preparedness metrics, tools and technology for an effective hematology launch. It also highlights the critical success factors and pitfalls for Medical Affairs during hematology launch.

KEY TOPICS

• Hematology launch timeline overview
• Hematology launch resourcing
• Hematology launch enablers

• Please indicate the time when each Medical Affairs group ideally should get involved in hematology product launch activities and when each group actually becomes involved
• Indicate the percentage of total Medical Affairs launch budget allocated to each of the listed activities
• Indicate the percentage of total Medical Affairs staffing allocated to each of the listed activities
• Have you developed a launch dashboard to measure the value and impact of Medical Affairs role in hematology launch success and to monitor launch progress?
• In your experience, what have been the critical success factors that drive successful hematology launches for Medical Affairs?
• What are the major pitfalls for Medical Affairs during hematology product launches?

• Put in place a feedback loop to leverage insights from the field to influence brand team’s activities:

  Generate insights around drug and competition. Translate these insights into tactical actions. Adjust launch preparation based on this intel. Medical Affairs’ access to the field is a tool it can leverage to influence other functions and change the launch strategy.
  

Best Practices, LLC engaged 19 hematology Medical Affairs experts from 14 pharmaceutical and biotechnology companies in this research study through a benchmarking survey, interviews and a roundtable discussion.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.